Connect Biopharma Holdings
CNTB · NASDAQ
$0.8752−$0.0246 (−2.73%)TodayMarket closed ·
Prev close $0.8998
Who owns CNTB
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 73.4% of CNTB’s shares.
- Panacea Venture20.9%
- BioFortune Inc9.5%
- Qiming Venture Partners7.7%
- Shanghai Minhui Enterprise Management Consulting Partnership7.6%
- Next 6 largest institutions27.7%
- All other shareholders26.6%
| Holder | Shares | % of shares |
|---|---|---|
| Panacea Venture | 13.16M | 20.90% |
| BioFortune Inc | 5.99M | 9.51% |
| Qiming Venture Partners | 4.84M | 7.69% |
| Shanghai Minhui Enterprise Management Consulting Partnership | 4.79M | 7.61% |
| Advantech Capital II L.P. | 4.76M | 7.56% |
| Ikarian Capital LLC | 4.54M | 7.21% |
| Lilly Asia Ventures | 3.34M | 5.30% |
| Wei (Zheng) | 2.52M | 4.00% |
| 683 Capital Management LLC | 1.28M | 2.04% |
| Boothbay Fund Management, LLC | 973.73K | 1.55% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| iShares Russell 2000 Growth ETF | 382.53K | 0.61% |
| iShares Russell 2000 ETF | 382.39K | 0.61% |
| Fidelity Small Cap Index Fund | 160.83K | 0.26% |
| Vanguard Russell 2000 Index Fund | 86.28K | 0.14% |
| Fidelity NASDAQ Composite Index Fund | 58.03K | 0.09% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $371.61K (1 trade) of CNTB on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Xanthopoulos Kleanthis Gabriel | Award | 5.00K | — |
| LIU JEAN I | Award | 8.98K | — |
| Xanthopoulos Kleanthis Gabriel | Award | 3.74K | — |
| LIU JEAN I | Award | 6.72K | — |
| Huang James | Buy | 150.00K | $371.61K |
Short interest
Settled Sep 30, 2026
- Shares short
- 3.50M
- Days to cover
- 1.00
- % of shares outstanding
- 5.56%
- Average daily volume
- 15.99M
- Change since last report
- +26.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.